Stock Track | iRhythm Technologies Plummets 5.11% Intraday Despite Strong Earnings as Analysts Cut Price Targets

Stock Track

Feb 20

iRhythm Technologies Inc. (IRTC) saw its shares plummet 5.11% during intraday trading on Friday, as the stock faced selling pressure following a series of analyst price target reductions.

Despite reporting strong quarterly earnings that significantly beat estimates, with adjusted EPS of $0.29 versus the $0.03 consensus expectation and revenue of $208.89 million exceeding the $201.59 million forecast, multiple Wall Street firms have recently lowered their price targets on the healthcare technology company.

JP Morgan reduced its target to $215 from $240, Canaccord lowered its target to $198 from $212, and Truist Securities adjusted its price target to $200 from $215, though all three firms maintained their Buy ratings on the stock. These downward revisions in price targets appear to be weighing on investor sentiment despite the company's solid financial performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1192004715"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192004715\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192004715?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-20 23:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192004715","market":"sg","top_or_hot":-1,"title":"Stock Track | iRhythm Technologies Plummets 5.11% Intraday Despite Strong Earnings as Analysts Cut Price Targets","media":"Stock Track","content":"<p>iRhythm Technologies Inc. (IRTC) saw its shares plummet 5.11% during intraday trading on Friday, as the stock faced selling pressure following a series of analyst price target reductions.</p><p>Despite reporting strong quarterly earnings that significantly beat estimates, with adjusted EPS of $0.29 versus the $0.03 consensus expectation and revenue of $208.89 million exceeding the $201.59 million forecast, multiple Wall Street firms have recently lowered their price targets on the healthcare technology company.</p><p>JP Morgan reduced its target to $215 from $240, Canaccord lowered its target to $198 from $212, and Truist Securities adjusted its price target to $200 from $215, though all three firms maintained their Buy ratings on the stock. These downward revisions in price targets appear to be weighing on investor sentiment despite the company's solid financial performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | iRhythm Technologies Plummets 5.11% Intraday Despite Strong Earnings as Analysts Cut Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | iRhythm Technologies Plummets 5.11% Intraday Despite Strong Earnings as Analysts Cut Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-20 23:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>iRhythm Technologies Inc. (IRTC) saw its shares plummet 5.11% during intraday trading on Friday, as the stock faced selling pressure following a series of analyst price target reductions.</p><p>Despite reporting strong quarterly earnings that significantly beat estimates, with adjusted EPS of $0.29 versus the $0.03 consensus expectation and revenue of $208.89 million exceeding the $201.59 million forecast, multiple Wall Street firms have recently lowered their price targets on the healthcare technology company.</p><p>JP Morgan reduced its target to $215 from $240, Canaccord lowered its target to $198 from $212, and Truist Securities adjusted its price target to $200 from $215, though all three firms maintained their Buy ratings on the stock. These downward revisions in price targets appear to be weighing on investor sentiment despite the company's solid financial performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRTC","symbol_name":"Irhythm Technologies Inc.","start_time":0,"source_url":"","article_id":"1192004715","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192004715","pubTimestamp":1771600839,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"iRhythm Technologies Inc. (IRTC) saw its shares plummet 5.11% during intraday trading on Friday, as the stock faced selling pressure following a series of analyst price target reductions.Despite...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IRTC":"Irhythm Technologies Inc."},"translate_title":"个股追踪|iRhythm Technologies盘中暴跌5.11%，尽管盈利强劲，分析师下调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRTC":1},"content_text":"iRhythm Technologies Inc. (IRTC) saw its shares plummet 5.11% during intraday trading on Friday, as the stock faced selling pressure following a series of analyst price target reductions.Despite reporting strong quarterly earnings that significantly beat estimates, with adjusted EPS of $0.29 versus the $0.03 consensus expectation and revenue of $208.89 million exceeding the $201.59 million forecast, multiple Wall Street firms have recently lowered their price targets on the healthcare technology company.JP Morgan reduced its target to $215 from $240, Canaccord lowered its target to $198 from $212, and Truist Securities adjusted its price target to $200 from $215, though all three firms maintained their Buy ratings on the stock. These downward revisions in price targets appear to be weighing on investor sentiment despite the company's solid financial performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}